Table 1 Demographics and clinical characteristics between the LG and RAG groups
LG (n = 110) | RAG (n = 16) | p value | |
|---|---|---|---|
Age (years) | 56.90 ± 9.90 | 54.44 ± 12.07 | 0.1510 |
Gender (male, %) | 77 (70.00%) | 10 (62.50%) | 0.5698 |
ASA-PS | 0.1464 | ||
II | 41 (37.27%) | 3 (18.75%) | |
III | 69 (62.73%) | 13 (81.25%) | |
Comorbidities | |||
Cardiovascular | 29 (26.36%) | 7 (43.75%) | 0.2533 |
Diabetes type 2 | 7 (6.36%) | 1 (6.25%) | > 0.9999 |
Viral hepatitis | 7 (6.36%) | 2 (12.50%) | 0.7106 |
Competing diseases | |||
Prostate cancer | 1 (0.91%) | 0 (0.00%) | > 0.9999 |
Esophageal cancer | 0 (0.00%) | 1 (6.25%) | 0.1270 |
Thyroid cancer | 0 (0.00%) | 1 (6.25%) | 0.1270 |
BMI (kg/m2) | 23.08 ± 2.70 | 24.14 ± 3.68 | 0.1684 |
Tumor location | 0.2348 | ||
Upper third | 29 | 1 | – |
Middle third | 25 | 5 | – |
Lower third | 56 | 10 | – |
Histological type | 0.7870 | ||
Well/moderate | 38 | 6 | – |
Poor/undifferentiated | 72 | 10 | – |